__timestamp | Supernus Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
---|---|---|
Wednesday, January 1, 2014 | 116287000 | 1256834000000 |
Thursday, January 1, 2015 | 136004000 | 1271973000000 |
Friday, January 1, 2016 | 203017000 | 1173296000000 |
Sunday, January 1, 2017 | 287023000 | 1274610000000 |
Monday, January 1, 2018 | 393541000 | 1437534000000 |
Tuesday, January 1, 2019 | 376095000 | 2201424000000 |
Wednesday, January 1, 2020 | 467938000 | 2203504000000 |
Friday, January 1, 2021 | 504714000 | 2462160000000 |
Saturday, January 1, 2022 | 580017000 | 2783406000000 |
Sunday, January 1, 2023 | 523742000 | 2832257000000 |
Monday, January 1, 2024 | 2832257000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, financial performance is a key indicator of success. This analysis compares the gross profit trends of Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Takeda, a global leader, consistently outperformed Supernus, with gross profits peaking at approximately 2.83 trillion in 2023, marking a 125% increase from 2014. In contrast, Supernus, a smaller player, showed impressive growth, with gross profits rising by nearly 350% over the same period, reaching around 580 million in 2022. However, 2023 saw a slight dip to 524 million. This data highlights Takeda's dominance in scale, while Supernus showcases remarkable growth potential. The absence of data for Supernus in 2024 suggests a need for further investigation. This financial narrative underscores the dynamic nature of the pharmaceutical industry, where both giants and emerging players shape the landscape.
Gross Profit Trends Compared: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Pfizer Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Bristol-Myers Squibb Company and Supernus Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Teva Pharmaceutical Industries Limited
Takeda Pharmaceutical Company Limited and Bio-Techne Corporation: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Amneal Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Evotec SE
Who Generates Higher Gross Profit? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Exelixis, Inc. or Supernus Pharmaceuticals, Inc.